|1.||Brouwers, Adrienne H: 2 articles (05/2012 - 04/2008)|
|2.||Schaefer, Oliver: 2 articles (12/2010 - 01/2004)|
|3.||Neumann, Hartmut P H: 2 articles (12/2010 - 01/2004)|
|4.||Itoh, K: 2 articles (01/2001 - 02/2000)|
|5.||Bhurke, Sharvari: 1 article (02/2015)|
|6.||Brulais, Siham: 1 article (02/2015)|
|7.||Chen, Shin-Yin: 1 article (02/2015)|
|8.||Chuang, Chien-Chia: 1 article (02/2015)|
|9.||Gabriel, Sylvie: 1 article (02/2015)|
|10.||Kudnig, Simon T: 1 article (10/2012)|
04/01/2010 - "The aim of our study is to demonstrate the feasibility of body diffusion weighted (DW) MR imaging in the evaluation of pancreatic islet cell tumors (ICTs) and to define apparent diffusion coefficient (ADC) values for these tumors. "
04/01/1987 - "A subsequent study demonstrated it in pancreatic islet cells and certain neuroendocrine (NE) neoplasms, including several pancreatic islet cell tumors. "
10/15/2012 - "Histologic evaluation indicated the masses were pancreatic islet cell tumors with tumor thrombi. "
01/01/2006 - "This article reviews the current clinical management of pancreatic islet cell tumors and describes the molecular events that have been studied to guide future therapies of these peculiar neoplasms. "
01/01/2006 - "Neoplasms of the endocrine pancreas, commonly referenced as pancreatic islet cell tumors, are rare, often well differentiated endocrine neoplasms, whose biology remains poorly characterized. "
|2.||Carcinoid Tumor (Carcinoid)
02/01/2015 - "Using a US administrative claims database, this study identified commercially-insured adults newly diagnosed with carcinoid tumors (ICD-9-CM: 209.xx) or pancreatic islet cell tumors (ICD-9-CM: 157.4 and 211.7) between July 1, 2007 and December 31, 2010 (date of first observed diagnosis denoted the index date). "
01/01/1989 - "The other 14 NETs were 10 pancreatic islet-cell tumors and four intestinal carcinoids, both diagnosed more frequently in metastatic than in primary sites (10 of 14 in the liver in this series). "
01/01/1994 - "Presenting in highly variable fashions, carcinoid tumors and pancreatic endocrine tumors share natural histories that may range from the serendipitously found, easily cured appendiceal carcinoid to the highly malignant pancreatic islet cell tumors associated with unique endocrine syndromes. "
10/01/2004 - "The two assays had different accuracy also in classifying patients according to their clinical condition (91% vs 64% specificity and 79% vs 79% sensitivity for the ELISA and IRMA assay, respectively) and tumor histology (81% vs 85% sensitivity for the ELISA and IRMA assays, respectively, in carcinoids; 92% vs 67% sensitivity for the ELISA and IRMA assays, respectively, in pancreatic islet cell tumors). "
01/01/1988 - "At the Medical University of South Carolina in Charleston, from March 1982 through September 1987, we have managed four patients with nonfunctioning pancreatic islet cell tumors or carcinoids, which presented with attacks of pancreatitis. "
12/01/1987 - "Nuclear DNA cytometric studies appear to offer promise as an aid in the evaluation of pancreatic islet cell tumors, particularly gastrinomas."
02/01/1979 - "Pancreatic islet cell tumors:insulinoma, gastrinoma, and glucagonoma."
04/08/1999 - "The close anatomical relationship of the exocrine and endocrine pancreas prompted us to determine the role of DPC4 in the tumorigenesis of 25 pancreatic islet cell tumors (11 insulinomas, nine non-functioning endocrine carcinomas, three gastrinomas, two vipomas). "
01/01/1984 - "To evaluate the usefulness of alpha-1-antitrypsin as a tumor marker for pancreatic islet cell tumors, serum levels were measured in 16 patients including 4 with gastrinomas, 4 with glucagonomas, 1 with a malignant somatostatinoma 1 with a malignant insulinoma, and 6 with "nonfunctioning" islet cell carcinoma and in 10 controls. "
|4.||Renal Cell Carcinoma (Grawitz Tumor)
04/01/2002 - "Progression to malignancy in VHL disease is associated primarily with the development of renal cell carcinoma (RCC) and pancreatic islet cell tumors (PICT). "
03/01/2007 - "Studies are needed to investigate all aspects of hot flashes in populations other than those with breast cancer, such as men with prostate cancer, carcinoid tumors, medullary thyroid tumors, pancreatic islet-cell tumors, renal cell carcinoma, and phenochromocytoma."
07/01/1997 - "These include flushing due to systemic diseases, carcinoid syndrome, systemic mast cell disease, pheochromocytoma, medullary carcinoma of the thyroid, pancreatic islet-cell tumors, renal cell carcinoma, neurological flushing, emotional flushing, spinal cord injury, flushing reaction related to alcohol and drugs, flushing associated with food additives and eating. "
|4.||DNA (Deoxyribonucleic Acid)
|7.||Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))